Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting

Oct 24, 2024

Posted by Pharvaris, Inc.

Biointron’s Q3 2024 Antibody Industry Report is OUT NOW!

Oct 17, 2024

Posted by Biointron Biological

Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus

Oct 16, 2024

Posted by Cullinan Therapeutics

EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries

Oct 16, 2024

Posted by EVERSANA

Join Our Upcoming Webinar on LNP Characterization on Thursday, October 31st!

Oct 16, 2024

Posted by Phosphorex

VIDEO: Driving Biopharma Forward—The Role of Technology in Commercialization

Oct 16, 2024

Posted by Corval

EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model

Oct 10, 2024

Posted by EVERSANA

Lundbeck Global Golden Ticket Competition

Oct 08, 2024